Nikolas LakoFollowThe Ohio State University1 paperOpenAlex ↗PapersThe Annals of PharmacotherapyReview·26 SepLerodalcibep-liga as an Injectable Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)-Targeted Therapy for Patients With Hypercholesterolemia
The Annals of PharmacotherapyReview·26 SepLerodalcibep-liga as an Injectable Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)-Targeted Therapy for Patients With Hypercholesterolemia